Stocks and Investing Stocks and Investing
Thu, November 16, 2023
Wed, November 15, 2023

Ross Osborn Maintained (SMTI) at Buy with Decreased Target to $49 on, Nov 15th, 2023


Published on 2024-10-28 07:36:07 - WOPRAI, Ross Osborn
  Print publication without navigation


Ross Osborn of Cantor Fitzgerald, Maintained "Sanara MedTech Inc." (SMTI) at Buy with Decreased Target from $59 to $49 on, Nov 15th, 2023.

Ross has made no other calls on SMTI in the last 4 months.



There is 1 other peer that has a rating on SMTI. Out of the 1 peers that are also analyzing SMTI, 0 agree with Ross's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ross


  • Brandon Folkes of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $59 on, Tuesday, September 26th, 2023
Contributing Sources